# CNCMT：a Multi-center, Prospective, Single-arm Study

> **NCT06714084** · NA · ENROLLING_BY_INVITATION · sponsor: **Hubei Cancer Hospital** · enrollment: 20 (estimated)

## Conditions studied

- Locally Advanced Cervical Cancer
- PD1
- CTLA4

## Interventions

- **DRUG:** Neoadjuvant Chemotherapy (NACT)
- **DRUG:** maintenance therapy

## Key facts

- **NCT ID:** NCT06714084
- **Lead sponsor:** Hubei Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2024-10-08
- **Primary completion:** 2025-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-12-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06714084

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06714084, "CNCMT：a Multi-center, Prospective, Single-arm Study". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT06714084. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*